Complications associated with the use of hyaluronic acid and their management - a literature review
DOI:
https://doi.org/10.12775/QS.2025.40.59462Keywords
hyaluronic acid, hyaluronidase, complicationsAbstract
Introduction: Aesthetic medicine is a rapidly growing field, as evidenced by statistics from the American Society of Plastic Surgeons. Like any medical procedure, treatments with hyaluronic acid (HA) fillers carry a risk of complications or adverse effects. These complications can be broadly categorized into non-vascular and vascular events. Non-vascular complications include nodules, granulomas, oedema, Tyndall effect, infections, and biofilm formation. Vascular complications encompass ischemia, necrosis, and severe outcomes such as blindness or other visual impairments.
Purpose: This study aims to compile and analyze current data on HA filler treatments and their associated complications within the scope of aesthetic dermatology.
Materials and Methods: A comprehensive manual review of scientific databases, including Scopus, EMBASE, and Medline, was conducted for articles published up to November 2024.
Summary: This review underscores the spectrum of complications related to HA fillers, emphasizing the importance of prevention, early diagnosis, and appropriate management. Although HA fillers are generally regarded as safe, the potential for complications persists. This reinforces the necessity of meticulous preparation, adherence to established guidelines, and continuous education for clinicians. Such measures can significantly minimize the incidence and severity of adverse events, thereby improving patient outcomes.
References
1. Surgeons, A.S.o.P., 2013 Plastic Surgery Statistics Report. 2013.
2. Surgeons, A.S.o.P., 2023 Plastic Surgery Statistics Report. 2023.
3. Bhojani-Lynch, T., et al., A Prospective, Observational Registry Study to Evaluate Effectiveness and Safety of Hyaluronic Acid-Based Dermal Fillers in Routine Practice: Interim Analysis Results with One Year of Subject Follow-Up. Clinical, Cosmetic and Investigational Dermatology, 2021. 14(null): p. 1685-1695.
4. Borzabadi-Farahani, A., A. Mosahebi, and D. Zargaran, A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions. Aesthetic Plastic Surgery, 2024. 48(6): p. 1193-1209.
5. Alam, M., et al., Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial. JAMA Dermatology, 2018. 154(7): p. 765-772.
6. Shahrabi Farahani, S., et al., Lip Nodules Caused by Hyaluronic Acid Filler Injection: Report of Three Cases. Head and Neck Pathology, 2012. 6(1): p. 16-20.
7. Park, T.-H., et al., Clinical experience with Hyaluronic acid-filler complications. Journal of Plastic, Reconstructive & Aesthetic Surgery, 2011. 64(7): p. 892-896.
8. Hall, M. and B.P. Glick, Complications of hyaluronic fillers. Dermatological Reviews, 2020. 1(2): p. 51-54.
9. Alsaad, S.M., S.G. Fabi, and M.P. Goldman, Granulomatous Reaction to Hyaluronic Acid: A Case Series and Review of the Literature. Dermatologic Surgery, 2012. 38(2 Part 1): p. 271-276.
10. Alcântara, C.E.P., et al., Granulomatous reaction to hyaluronic acid filler material in oral and perioral region: A case report and review of literature. Journal of Cosmetic Dermatology, 2018. 17(4): p. 578-583.
11. Cavallieri, F.A., et al., Persistent, intermitent delayed swelling PIDS: late adverse reaction to hyaluronic acid fillers. CEP, 2017. 22440: p. 040.
12. Kopp, S., et al., Delayed Migration of Hyaluronic Acid Fillers: A New Complication? Dermatologic Surgery, 2014. 40(1): p. 85-87.
13. Abduljabbar, M.H. and M.A. Basendwh, Complications of hyaluronic acid fillers and their managements. Journal of Dermatology & Dermatologic Surgery, 2016. 20(2): p. 100-106.
14. Aviv, U., et al., Treatment Algorithm for Hyaluronic Acid-Related Complication Based on a Systematic Review of Case Reports, Case Series, and Clinical Experience. Craniomaxillofac Trauma Reconstr, 2020. 13(4): p. 313-328.
15. Kim, D.Y., J.S. Eom, and J.Y. Kim, Temporary blindness after an anterior chamber cosmetic filler injection. Aesthetic Plast Surg, 2015. 39(3): p. 428-30.
16. Zhang, L., et al., Clinical Observations and the Anatomical Basis of Blindness After Facial Hyaluronic Acid Injection. Aesthetic Plast Surg, 2019. 43(4): p. 1054-1060.
17. Lazzeri, D., et al., Blindness following cosmetic injections of the face. Plast Reconstr Surg, 2012. 129(4): p. 995-1012.
18. Carle, M.V., et al., Cosmetic facial fillers and severe vision loss. JAMA Ophthalmol, 2014. 132(5): p. 637-9.
19. Murray, G., et al., Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion. J Clin Aesthet Dermatol, 2021. 14(5): p. E61-e69.
20. Wang, R., et al., Hyaluronic acid filler-induced vascular occlusion-Three case reports and overview of prevention and treatment. J Cosmet Dermatol, 2024. 23(4): p. 1217-1223.
21. Signorini, M., et al., Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers-Evidence- and Opinion-Based Review and Consensus Recommendations. Plast Reconstr Surg, 2016. 137(6): p. 961e-971e.
22. Mortimer, P.S. and S.G. Rockson, New developments in clinical aspects of lymphatic disease. J Clin Invest, 2014. 124(3): p. 915-21.
23. Philipp-Dormston, W.G., et al., Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers. J Eur Acad Dermatol Venereol, 2017. 31(7): p. 1088-1095.
24. Beauvais, D. and E.M. Ferneini, Complications and Litigation Associated With Injectable Facial Fillers: A Cross-Sectional Study. J Oral Maxillofac Surg, 2020. 78(1): p. 133-140.
25. Sclafani, A.P. and S. Fagien, Treatment of injectable soft tissue filler complications. Dermatol Surg, 2009. 35 Suppl 2: p. 1672-80.
26. Ha, R.Y., et al., Analysis of facial skin thickness: defining the relative thickness index. Plast Reconstr Surg, 2005. 115(6): p. 1769-73.
27. Vasquez, R.A.S., et al., Prolonged Periorbicular Edema After Injection of Hyaluronic Acid for Nasojugal Groove Correction. J Clin Aesthet Dermatol, 2019. 12(9): p. 32-35.
28. Zegarska, B., et al., Management of complications associated with the use of hyaluronic acid fillers. Recommendations of the Aesthetic Dermatology Section of the Polish Dermatological Society. Dermatology Review/Przegląd Dermatologiczny, 2020. 107(1): p. 15-31.
29. Guthrie, A., et al., A Review of Complications and Their Treatments in Facial Aesthetic Surgery. The American Journal of Cosmetic Surgery, 2017. 34(2): p. 73-80.
30. Marxen, T., et al., The Utility of Lymphatic Massage in Cosmetic Procedures. Aesthet Surg J Open Forum, 2023. 5: p. ojad023.
31. Dayan, E., et al., Aesthetic Applications of Radiofrequency: Lymphatic and Perfusion Assessment. Plast Reconstr Surg Glob Open, 2020. 8(10): p. e3193.
32. King, M., C. Convery, and E. Davies, This month's guideline: The Use of Hyaluronidase in Aesthetic Practice (v2.4). J Clin Aesthet Dermatol, 2018. 11(6): p. E61-e68.
33. King, M., Management of Tyndall Effect. J Clin Aesthet Dermatol, 2016. 9(11): p. E6-e8.
34. Niamtu, J., 3rd, Complications in fillers and Botox. Oral Maxillofac Surg Clin North Am, 2009. 21(1): p. 13-21, v.
35. Cho, S.B., et al., Effective treatment of a injected hyaluronic acid-induced Tyndall effect with a 1064-nm Q-switched Nd:YAG laser. Clin Exp Dermatol, 2009. 34(5): p. 637-8.
36. Olaiya, O.R., et al., Hyaluronidase for Treating Complications Related to HA Fillers: A National Plastic Surgeon Survey. Plast Surg (Oakv), 2022. 30(3): p. 233-237.
37. Otto, M., How Staphylococcus aureus breaches our skin to cause infection. J Infect Dis, 2012. 205(10): p. 1483-5.
38. Martinez, N., Skin and Soft-Tissue Infections: It's More Than Just Skin Deep. Adv Emerg Nurs J, 2020. 42(3): p. 196-203.
39. Funt, D. and T. Pavicic, Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Plast Surg Nurs, 2015. 35(1): p. 13-32.
40. Christensen, L.H., Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg, 2009. 35 Suppl 2: p. 1612-9.
41. Barańska-Rybak, W., Powikłania po korekcji zmarszczek kwasem hialuronowym – postępowanie i leczenie. Dermatol Dypl 2015(5): p. 1-7.
42. Wang, C., et al., Herpes reactivation after the injection of hyaluronic acid dermal filler: A case report and review of literature. Medicine (Baltimore), 2020. 99(24): p. e20394.
43. Gazzola, R., L. Pasini, and M. Cavallini, Herpes virus outbreaks after dermal hyaluronic acid filler injections. Aesthet Surg J, 2012. 32(6): p. 770-2.
44. Cernik, C., K. Gallina, and R.T. Brodell, The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med, 2008. 168(11): p. 1137-44.
45. Netsvyetayeva, I., et al., Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation. Infect Drug Resist, 2018. 11: p. 213-222.
46. Høiby, N., et al., The clinical impact of bacterial biofilms. Int J Oral Sci, 2011. 3(2): p. 55-65.
47. Hall-Stoodley, L., et al., Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol, 2012. 65(2): p. 127-45.
48. Høiby, N., et al., Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents, 2010. 35(4): p. 322-32.
49. Saththianathan, M., et al., The Role of Bacterial Biofilm in Adverse Soft-Tissue Filler Reactions: A Combined Laboratory and Clinical Study. Plast Reconstr Surg, 2017. 139(3): p. 613-621.
50. DeLorenzi, C., Complications of Injectable Fillers, Part I. Aesthetic Surgery Journal, 2013. 33(4): p. 561-575.
51. Marusza, W., et al., Treatment of late bacterial infections resulting from soft-tissue filler injections. Infect Drug Resist, 2019. 12: p. 469-480.
52. Baranska-Rybak, W., et al., Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management. Dermatol Ther (Heidelb), 2024. 14(7): p. 1767-1785.
53. Trinh, L.N., K.C. McGuigan, and A. Gupta, Delayed Granulomas as a Complication Secondary to Lip Augmentation with Dermal Fillers: A Systematic Review. Surg J (N Y), 2022. 8(1): p. e69-e79.
54. Modarressi, A., C. Nizet, and T. Lombardi, Granulomas and nongranulomatous nodules after filler injection: Different complications require different treatments. J Plast Reconstr Aesthet Surg, 2020. 73(11): p. 2010-2015.
55. King, M., et al., Management of Delayed Onset Nodules. J Clin Aesthet Dermatol, 2016. 9(11): p. E1-e5.
56. Philipp-Dormston, W.G., et al., Global Approaches to the Prevention and Management of Delayed-onset Adverse Reactions with Hyaluronic Acid-based Fillers. Plast Reconstr Surg Glob Open, 2020. 8(4): p. e2730.
57. Ostezan, L. and J. Peck, Radial Sound (Shockwave) Therapy Resolves Delayed-onset Nodules Following Injection of Hyaluronic Acid Dermal Filler: A Case Study. J Clin Aesthet Dermatol, 2021. 14(12 Suppl 1): p. S15-s17.
58. Caldas Pozuelo, C., J. Domínguez De Dios, and X. Mota Rojas, Multiple oral granulomatous nodules to hyaluronic acid filler. J Cosmet Dermatol, 2020. 19(12): p. 3453-3455.
59. Beleznay, K., et al., Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg, 2015. 41(8): p. 929-39.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Magda Turczynowicz, Karina Lewandowska, Wojciech Janikowski, Agnieszka Jóźwicka, Natalia Radwańska, Weronika Górska, Jerzy Król

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1407
Number of citations: 0